These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23231879)

  • 1. Roles in and barriers to metabolic screening for people taking antipsychotic medications: a survey of psychiatrists.
    Parameswaran SG; Chang C; Swenson AK; Shumway M; Olfson M; Mangurian CV
    Schizophr Res; 2013 Feb; 143(2-3):395-6. PubMed ID: 23231879
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary care providers' views on metabolic monitoring of outpatients taking antipsychotic medication.
    Mangurian C; Giwa F; Shumway M; Fuentes-Afflick E; Pérez-Stable EJ; Dilley JW; Schillinger D
    Psychiatr Serv; 2013 Jun; 64(6):597-9. PubMed ID: 23728604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring for the metabolic side effects of second-generation antipsychotic medications: Psychiatrists' views and practices.
    Abdulhaq B; Dardas LA; Sami O
    Perspect Psychiatr Care; 2021 Jul; 57(3):1237-1243. PubMed ID: 33156542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolic disorders in patients with schizophrenia treated with atypical antipsychotic drugs].
    Gorobets LN; Bulanov VS; Vasilenko LM; Litvinov AV; Poliakovskaia TP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9):90-6. PubMed ID: 23373080
    [No Abstract]   [Full Text] [Related]  

  • 5. Patient, Treatment, and Health Care Utilization Variables Associated with Adherence to Metabolic Monitoring Practices in Children and Adolescents Taking Second-Generation Antipsychotics.
    Coughlin M; Goldie CL; Tranmer J; Khalid-Khan S; Tregunno D
    Can J Psychiatry; 2018 Apr; 63(4):240-249. PubMed ID: 29528720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic and endocrine disturbances in psychiatric disorders: a multidisciplinary approach to appropriate atypical antipsychotic utilization.
    Masand PS; Culpepper L; Henderson D; Lee S; Littrell K; Newcomer JW; Rasgon N
    CNS Spectr; 2005 Oct; 10(10):suppl14 1-15. PubMed ID: 16404802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers to utilizing long-acting injectable antipsychotic medications.
    Getzen H; Beasley M; D'Mello DA
    Ann Clin Psychiatry; 2014 Feb; 26(1):33-8. PubMed ID: 24660225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in metabolic monitoring of second-generation antipsychotic prescription.
    Verdoux H; Boulon S; Cougnard A
    Hum Psychopharmacol; 2008 Aug; 23(6):471-4. PubMed ID: 18512735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to utilizing long-acting injectable antipsychotic medications.
    Getzen H; Beasley M; D'Mello DA
    Ann Clin Psychiatry; 2013 Nov; 25(4):E1-6. PubMed ID: 24199223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.
    De Hert M; Detraux J; van Winkel R; Yu W; Correll CU
    Nat Rev Endocrinol; 2011 Oct; 8(2):114-26. PubMed ID: 22009159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychiatrists' decision making and monitoring of antipsychotic prescription for elderly schizophrenia patients].
    Jalenques I; Ortega V; Legrand G; Auclair C
    Encephale; 2016 Apr; 42(2):124-9. PubMed ID: 26796558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for the metabolic syndrome in Australia: a national survey of psychiatrists' attitudes and reported practice in patients prescribed antipsychotic drugs.
    Laugharne J; Waterreus AJ; Castle DJ; Dragovic M
    Australas Psychiatry; 2016 Feb; 24(1):62-6. PubMed ID: 26635377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular and metabolic monitoring of children and adolescents on antipsychotic treatment: A cross-sectional descriptive study.
    de la Torre Villalobos M; Martin-López LM; Fernández Sanmartín MI; Pujals Altes E; Gasque Llopis S; Batlle Vila S; Pérez-Solá V; Novo Navarro P; Gómez Simón I; Fresno González C; Camprodon Rosanas E; Bulbena Vilarrasa A
    Rev Psiquiatr Salud Ment (Engl Ed); 2018; 11(1):19-26. PubMed ID: 27291832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of a computer reminder system for laboratory monitoring of metabolic syndrome in schizophrenic outpatients using second-generation antipsychotics.
    Lai CL; Chan HY; Pan YJ; Chen CH
    Pharmacopsychiatry; 2015 Jan; 48(1):25-9. PubMed ID: 25350604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of monitoring for metabolic effects associated with second generation antipsychotics in patients with schizophrenia on public insurance.
    Moeller KE; Rigler SK; Mayorga A; Nazir N; Shireman TI
    Schizophr Res; 2011 Mar; 126(1-3):117-23. PubMed ID: 21168994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opinions of Primary Care Clinicians and Psychiatrists on Monitoring the Metabolic Effects of Antipsychotics.
    Mangurian C; Giwa A; Brosey E; Shumway M; Dilley J; Fuentes-Afflick E; Pérez-Stable EJ; Schillinger D
    J Am Board Fam Med; 2019; 32(3):418-423. PubMed ID: 31068407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring metabolic side effects of atypical antipsychotics in people with an intellectual disability.
    Teeluckdharry S; Sharma S; O'Rourke E; Tharian P; Gondalekar A; Nainar F; Roy M
    J Intellect Disabil; 2013 Sep; 17(3):223-35. PubMed ID: 23801356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of monitoring practices for metabolic disease in antipsychotic-treated community psychiatric patients.
    Mackin P; Bishop DR; Watkinson HM
    BMC Psychiatry; 2007 Jun; 7():28. PubMed ID: 17592636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Atypical Antipsychotic Therapy and Metabolic Issues National Survey: practice patterns and knowledge of psychiatrists.
    Newcomer JW; Nasrallah HA; Loebel AD
    J Clin Psychopharmacol; 2004 Oct; 24(5 Suppl 1):S1-6. PubMed ID: 15356414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.